Adverum Biotechnologies, Inc.
ADVM
$4.17
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -204.39M | -189.09M | -170.40M | -150.53M | -118.66M |
| Total Depreciation and Amortization | 2.49M | 2.92M | 3.34M | 3.65M | 3.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.71M | 34.78M | 40.10M | 42.15M | 29.81M |
| Change in Net Operating Assets | 33.28M | 20.48M | 14.98M | 12.26M | -540.00K |
| Cash from Operations | -137.90M | -130.91M | -111.99M | -92.46M | -85.54M |
| Capital Expenditure | -543.00K | -622.00K | -518.00K | -388.00K | -519.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.40M | 46.27M | 11.94M | -41.50M | -47.06M |
| Cash from Investing | 60.85M | 45.65M | 11.42M | -41.89M | -47.58M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.26M | 359.00K | 239.00K | 120.12M | 120.12M |
| Repurchase of Common Stock | -- | -- | -116.00K | -116.00K | -116.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -76.00K |
| Cash from Financing | 10.26M | 359.00K | 123.00K | 120.00M | 119.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.79M | -84.90M | -100.45M | -14.35M | -13.19M |